Reinhart Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-48,742
| Closed | -$7.34M | – | 77 |
|
|
2025
Q1 | $7.34M | Sell |
48,742
-1,934
| -4% | -$291K | 0.27% | 66 |
|
|
2024
Q4 | $9.35M | Sell |
50,676
-11,822
| -19% | -$2.18M | 0.36% | 60 |
|
|
2024
Q3 | $12.3M | Sell |
62,498
-4,547
| -7% | -$896K | 0.47% | 54 |
|
|
2024
Q2 | $13.9M | Sell |
67,045
-4,779
| -7% | -$987K | 0.58% | 45 |
|
|
2024
Q1 | $19.5M | Sell |
71,824
-1,071
| -1% | -$290K | 0.79% | 39 |
|
|
2023
Q4 | $17.2M | Sell |
72,895
-16,174
| -18% | -$3.82M | 0.76% | 39 |
|
|
2023
Q3 | $17.5M | Sell |
89,069
-3,954
| -4% | -$775K | 0.91% | 41 |
|
|
2023
Q2 | $19.6M | Sell |
93,023
-433
| -0.5% | -$91K | 0.99% | 41 |
|
|
2023
Q1 | $18.9M | Buy |
93,456
+24,952
| +36% | +$5.04M | 1.02% | 38 |
|
|
2022
Q4 | $14.9M | Buy |
68,504
+21,730
| +46% | +$4.73M | 0.81% | 57 |
|
|
2022
Q3 | $9.21M | Buy |
+46,774
| New | +$9.21M | 0.57% | 72 |
|